Although MMP-9 seems to reflect an overall burden of vascular disease in type 2 diabetes patients [8-13] it is still controversially discussed to use it as a reliable surrogate marker of CV risk to date [14-16]. The gene discussed is MMP9; the disease is type 2 diabetes mellitus.